A web-based support tool for patients with thyroid cancer after treatment
Official title: The development of a technology-based information support intervention (iSupport) among patients with differentiated thyroid cancer post radioactive iodine therapy
Funded at Georgetown University · NIH-11231962 · Data updated 2026-11-12
This study is testing a helpful online tool called iSupport for people with differentiated thyroid cancer who have had radioactive iodine treatment, to provide them with useful information and support to make their recovery easier and improve their quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | March 2, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $248,999 |
| NIH project number | 4R00CA277588-03 |
| Project ID | NIH-11231962 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with differentiated thyroid cancer who have recently undergone radioactive iodine therapy.
✕Less likely to help
Patients with thyroid cancer who have not received radioactive iodine therapy or those with advanced stages of cancer may not benefit from this research.
What this research studies
This research develops a digital intervention called iSupport aimed at helping patients with differentiated thyroid cancer (DTC) who have undergone radioactive iodine (RAI) therapy. The intervention will provide educational resources and support tools to address the significant symptom burden and informational needs that patients experience post-treatment. The project will involve creating the iSupport platform, testing its usability, and evaluating its effectiveness compared to standard care. By engaging patients through focus groups and interviews, the research aims to ensure that the intervention meets their needs and improves their quality of life.
Why it matters
Potential benefit: If successful, this research could significantly reduce the symptom burden and improve the quality of life for patients recovering from thyroid cancer treatment.
How similar studies have gone: Previous research has shown that digital interventions can effectively support cancer patients, indicating a promising avenue for this approach.
Where this research is happening
-
Georgetown University
Washington, United States Active
Researchers
- Principal investigator: Carr, Alaina L — Georgetown University
- Study coordinator: Carr, Alaina L
Related research
Other NIH-funded projects on the same topics.
-
Online support for people with differentiated thyroid cancer after radioactive iodine treatment
A web-based program to help people with differentiated thyroid cancer manage side effects and improve quality of life after radioactive iodine treatment.
-
WTC Dust and Thyroid Cancer Progression in Human Organoids
This grant tests how World Trade Center dust might influence thyroid cancer progression using human thyroid organoids to model real-life exposure.
-
Integrating molecular signals to guide thyroid cancer care
A doctor-scientist team at Brigham and Women’s Hospital is studying how tumor biology and the immune environment can guide personalized monitoring and treatment for differentiated thyroid cancer.
-
Metabolic Imaging to Track Treatment Response in Aggressive Thyroid Cancer
This grant explores a new way to watch how aggressive thyroid cancers respond to treatment using a special MRI technique that tracks tumor metabolism.
-
Adoptive T-cell Therapy for Anaplastic Thyroid Cancer
A patient-focused program explores using patient immune cells engineered to target and fight anaplastic thyroid cancer, especially for those whose cancer has stopped responding to standard treatments.
-
Overcoming Resistance to BRAF Inhibitors in Aggressive Thyroid Cancers
A patient-focused research effort to find new ways to treat difficult thyroid cancers that no longer respond to current BRAF inhibitors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.